ROYALTY PHARMA PLC revenue breakdown overview

ROYALTY PHARMA PLC revenue for the last year amounted to 51.74 B MXN, the most of which — 39.99 B MXN — came from its highest performing source at the moment, Biopharmaceutical Royalties, the year earlier bringing 43.64 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought ROYALTY PHARMA PLC 39.99 B MXN, and the year before that — 43.64 B MXN.